Related Experiment Video
Updated: Jun 6, 2025

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.6K
Investigating p.Ala1035Val in NPC1: New Cellular Models for Niemann-Pick Type C Disease
Hugo David1,2,3, Jlenia Monfregola4, Isaura Ribeiro5,6,7
1Research and Development Unit, Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge (INSA, I. P.), Rua Alexandre Herculano 321, 4000-055 Porto, Portugal.
International Journal of Molecular Sciences
|November 27, 2024
Summary
The p.Ala1035Val variant in Niemann-Pick type C (NPC) disease impairs NPC1 protein trafficking to lysosomes, similar to the p.Ile1061Thr variant. This variant, especially with the p.Ile858Val SNP, may worsen disease progression.
Area of Science:
- Cell Biology
- Genetics
- Biochemistry
Background:
- Niemann-Pick type C (NPC) is a lysosomal storage disorder (LSD) caused by mutations in NPC1 or NPC2 genes, affecting cholesterol transport.
- The p.Ile1061Thr NPC1 variant is common in Western Europe, while p.Ala1035Val is prevalent in Portugal and globally.
Purpose of the Study:
- To investigate the cellular impact of the p.Ala1035Val NPC1 variant, particularly its interaction with the p.Ile858Val single nucleotide polymorphism (SNP).
- To compare the functional consequences of p.Ala1035Val and p.Ile1061Thr variants on NPC1 protein trafficking and lysosomal positioning.
Main Methods:
- Created variant-specific in vitro models using NPC1-deficient ARPE-19 cells expressing fluorescently-tagged NPC1 variants.
- Utilized patient-derived skin fibroblasts for cellular analysis.
- Examined lysosomal positioning and NPC1 protein trafficking pathways.
Main Results:
- Confirmed reduced lysosomal trafficking for the p.Ile1061Thr variant.
- Demonstrated impaired lysosomal trafficking for the p.Ala1035Val variant, with a more severe effect when in cis with the p.Ile858Val SNP.
- Observed similar or worse lysosomal positioning issues with p.Ala1035Val compared to p.Ile1061Thr.
Conclusions:
- The p.Ala1035Val variant significantly impacts NPC1 protein trafficking to lysosomes.
- The co-occurrence of p.Ala1035Val and p.Ile858Val in cis may exacerbate NPC disease cellular phenotypes.
- This study provides the first functional insights into the p.Ala1035Val variant, opening avenues for targeted NPC therapies.

